Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Klaessens

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Molecular Biosciences|October 3, 2022
Systemic tryptophan homeostasisSimon Klaessens, Vincent Stroobant, Etienne De Plaen, et al.
Epigenetics|August 5, 2014
A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumorsAxelle Loriot, Aurélie Van Tongelen, Jordi Blanco, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2021
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenaseSimon Klaessens, Vincent Stroobant, Delia Hoffmann, et al.
Journal of Medicinal Chemistry|August 2, 2021
Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-DioxygenaseArina Kozlova, Léopold Thabault, Maxime Liberelle, et al.
Cancer Immunology Research|December 7, 2019
Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most CancersDelia Hoffmann, Tereza Dvorakova, Vincent Stroobant, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytesMarie Solvay, Pauline Holfelder, Simon Klaessens, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Molecular Biosciences|October 3, 2022
Systemic tryptophan homeostasisSimon Klaessens, Vincent Stroobant, Etienne De Plaen, et al.
Epigenetics|August 5, 2014
A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumorsAxelle Loriot, Aurélie Van Tongelen, Jordi Blanco, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2021
Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenaseSimon Klaessens, Vincent Stroobant, Delia Hoffmann, et al.
Journal of Medicinal Chemistry|August 2, 2021
Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-DioxygenaseArina Kozlova, Léopold Thabault, Maxime Liberelle, et al.
Cancer Immunology Research|December 7, 2019
Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most CancersDelia Hoffmann, Tereza Dvorakova, Vincent Stroobant, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytesMarie Solvay, Pauline Holfelder, Simon Klaessens, et al.
Pageof 1